Mikoda Nobuyuki, Sonoda Hiroko, Oshikawa Sayaka, Hoshino Yuya, Matsuzaki Toshiyuki, Ikeda Masahiro
Department of Veterinary Pharmacology, University of Miyazaki, Miyazaki, Japan.
Department of Anatomy and Cell Biology, Gunma University Graduate School of Medicine, Maebashi, Japan.
Physiol Rep. 2019 May;7(9):e14092. doi: 10.14814/phy2.14092.
The DBA/2-FG pcy (pcy) mouse is a model of human nephronophthisis, a recessive cystic kidney disease. Renal expression of aquaporin-2 (AQP2), a water channel protein, has been shown to be altered in pcy mice. However, the relationship between the renal expression and its release in urinary extracellular vesicles (uEV-AQP2), which account for most urinary AQP2, in pcy mice has remained largely unknown. In this study, we examined age-related alterations of this relationship in pcy mice. In comparison with control mice, pcy mice after the age of 14 weeks showed defective urinary concentration ability with an increase in urinary volume. Interestingly, the release of uEV-AQP2 increased progressively up to the age of 16 weeks, but at 21 weeks the release did not significantly differ from that in control mice (i.e., a bell-shaped pattern was evident). Similar results were obtained for uEV marker proteins, including tumor susceptibility gene 101 (TSG101) protein and apoptosis-linked gene 2-interacting protein X (Alix). Immunoblot analysis revealed that renal AQP2 expression increased progressively from 11 weeks, and immunohistochemistry showed that this increase was possibly due to an increase in the number of AQP2-positive cells. Analysis of mRNAs for seven types of AQP expressed in the kidney supported this notion. These data suggest that the level of uEV-AQP2 does not simply mirror the renal expression of AQP2 and that the altered release of uEV-AQP2 in pcy mice depends on the numbers of both renal AQP2-positive cells and EVs released into the urine.
DBA/2-FG pcy(pcy)小鼠是人类肾单位肾痨(一种隐性囊性肾病)的模型。水通道蛋白2(AQP2)是一种水通道蛋白,其在肾脏中的表达已被证明在pcy小鼠中发生了改变。然而,在pcy小鼠中,肾脏表达与其在占大多数尿AQP2的尿细胞外囊泡(uEV-AQP2)中的释放之间的关系在很大程度上仍不清楚。在本研究中,我们研究了pcy小鼠中这种关系的年龄相关变化。与对照小鼠相比,14周龄后的pcy小鼠表现出尿浓缩能力缺陷,尿量增加。有趣的是,uEV-AQP2的释放在16周龄前逐渐增加,但在21周时,其释放与对照小鼠相比无显著差异(即呈钟形模式)。对于包括肿瘤易感基因101(TSG101)蛋白和凋亡相关基因2相互作用蛋白X(Alix)在内的uEV标记蛋白,也得到了类似的结果。免疫印迹分析显示,肾脏AQP2表达从11周开始逐渐增加,免疫组织化学显示这种增加可能是由于AQP2阳性细胞数量增加所致。对肾脏中表达的七种AQP mRNA的分析支持了这一观点。这些数据表明,uEV-AQP2的水平并非简单地反映AQP2的肾脏表达,并且pcy小鼠中uEV-AQP2释放的改变取决于肾脏AQP2阳性细胞的数量以及释放到尿液中的细胞外囊泡的数量。